Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 5, 2009, Pages 1493-1500

  Heron, Dwight E ^a   Ferris, Robert L ^a   Karamouzis, Michalis ^a   Andrade, Regiane S ^a   Deeb, Erin L ^a   Burton, Steven ^a   Gooding, William E ^a   Branstetter, Barton F ^a   Mountz, James M ^a   Johnson, Jonas T ^a   Argiris, Athanassios ^a   Grandis, Jennifer R ^a   Lai, Stephen Y ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Head and neck cancer; Head and neck squamous cell carcinoma; PET CT; Reirradiation; Stereotactic body radiotherapy

Indexed keywords

ACUTE TOXICITY; CLINICAL TRIAL; COMPUTED TOMOGRAPHY; CONFIDENCE INTERVAL; CT VOLUME; DISEASE PROGRESSION; DOSE LIMITING TOXICITY; EVALUATION CRITERIA; F-FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE; HEAD-AND-NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PHASE I; QUALITY OF LIFE; REIRRADIATION; RESPONSE RATE; SOLID TUMORS; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; STANDARDIZED UPTAKE VALUES; STEREOTACTIC BODY RADIOTHERAPY;

COMPUTERIZED TOMOGRAPHY; RADIOTHERAPY; TOXICITY;

POSITRON EMISSION TOMOGRAPHY;

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE COURSE; DYSPHAGIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPERPIGMENTATION; LARYNX; MALE; MOUTH CAVITY; MUCOSA INFLAMMATION; NASOPHARYNX; OROPHARYNX; OVERALL SURVIVAL; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOSURGERY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETREATMENT; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 71649101387     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.075     Document Type: Article

References (43)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Munro A.J. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71 (1995) 83-91
3. Forastiere A., Koch W., Trotti A., et al. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
4. DeConti R.C., and Schoenfeld D. A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer 48 (1981) 1061-1072
5. Hong W.K., Bromer R.H., Amato D.A., et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 56 (1985) 1242-1245
6. Fontanesi J., Hetzler D., and Ross J. Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192. Int J Radiat Oncol Biol Phys 17 (1989) 365-369
7. Hong W.K., Schaefer S., Issell B., et al. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer 52 (1983) 206-210
8. Gibson M.K., Li Y., Murphy B., et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23 (2005) 3562-3567
9. Emami B., Bignardi M., Spector G.J., et al. Reirradiation of recurrent head and neck cancers. Laryngoscope 97 (1987) 85-88
10. Pomp J., Levendag P.C., and van Putten W.L. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 11 (1988) 543-549
11. Stevens Jr. K.R., Britsch A., and Moss W.T. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29 (1994) 687-698
12. Langer C.J., Harris J., Horwitz E.M., et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25 (2007) 4800-4805
13. Spencer S.A., Harris J., Wheeler R.H., et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 30 (2007) 281-288
14. Denekamp J., Stewart F.A., and Douglas B.G. Changes in the proliferation rate of mouse epidermis after irradiation continuous labeling studies. Cell Tissue Kinet 9 (1976) 19-29
15. Chen F.D., and Hendry J.H. Residual skin injury after repeated irradiation: Differences observed using healing, macrocolony, and microcolony endpoints. Int J Radiat Oncol Biol Phys 15 (1988) 943-948
16. Stewart F.A. Re-treatment after full-course radiotherapy: Is it a viable option?. Acta Oncol 38 (1999) 855-862
17. Adler Jr. J.R., Murphy M.J., Chang S.D., et al. Image-guided robotic radiosurgery. Neurosurgery 44 (1999) 1299-1306 discussion 1306-1307
18. King C.R., Lehmann J., Adler J.R., et al. CyberKnife radiotherapy for localized prostate cancer: Rationale and technical feasibility. Technol Cancer Res Treat 2 (2003) 25-30
19. Whyte R.I., Crownover R., Murphy M.J., et al. Stereotactic radiosurgery for lung tumors: Preliminary report of a phase I trial. Ann Thorac Surg 75 (2003) 1097-1101
20. Voynov G., Heron D.E., Burton S., et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 5 (2006) 529-535
21. Weymuller Jr. E.A., Alsarraf R., Yueh B., et al. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 127 (2001) 489-493
22. Young H., Baum R., Cremerius U., et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35 (1999) 1773-1782
23. Garofalo M.C., and Haraf D.J. Reirradiation: A potentially curative approach to locally or regionally recurrent head-and-neck cancer. Curr Opin Oncol 14 (2002) 330-333
24. Langendijk J.A., Kasperts N., Leemans C.R., et al. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 78 (2006) 306-312
25. Langendijk J.A., and Bourhis J. Reirradiation in squamous cell head and neck cancer: Recent developments and future directions. Curr Opin Oncol 19 (2007) 202-209
26. Wang C.C. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys 13 (1987) 953-956
27. Haraf D.J., Weichselbaum R.R., and Vokes E.E. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7 (1996) 913-918
28. De Crevoisier R., Bourhis J., Domenge C., et al. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16 (1998) 3556-3562
29. Salama J.K., and Vokes E.E. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol 35 (2008) 251-261
30. Biagioli M.C., Harvey M., Roman E., et al. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1067-1073
31. Lee N., Chan K., Bekelman J.E., et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 731-740
32. Emami B., and Marks J.E. Retreatment of recurrent carcinoma of the head and neck by afterloading interstitial 192Ir implant. Laryngoscope 93 (1983) 1345-1347
33. Jeremic B., Djuric L., and Mijatovic L. Incidence of radiation myelitis of the cervical spinal cord at doses of 5500 cGy or greater. Cancer 68 (1991) 2138-2141
34. Dawson L.A., Myers L.L., Bradford C.R., et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 377-385
35. Creak A.L., Harrington K., and Nutting C. Treatment of recurrent head and neck cancer: Re-irradiation or chemotherapy?. Clin Oncol (R Coll Radiol) 17 (2005) 138-147
36. Murphy B.A., Ridner S., Wells N., et al. Quality of life research in head and neck cancer: A review of the current state of the science. Crit Rev Oncol Hematol 62 (2007) 251-267
37. Rogers S.N., Ahad S.A., and Murphy A.P. A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. Oral Oncol 43 (2007) 843-868
38. Andrade R.S., Heron D.E., Degirmenci B., et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1315-1322
39. Porceddu S.V., Jarmolowski E., Hicks R.J., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
40. Yao M., Graham M.M., Smith R.B., et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: A preliminary report. Int J Radiat Oncol Biol Phys 60 (2004) 1410-1418
41. Shankar L.K., Hoffman J.M., Bacharach S., et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 47 (2006) 1059-1066
42. Ahn Y.C., Lee K.C., Kim D.Y., et al. Fractionated stereotactic radiation therapy for extracranial head and neck tumors. Int J Radiat Oncol Biol Phys 48 (2000) 501-505
43. Le Q.T., Tate D., Koong A., et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 56 (2003) 1046-1054